Perrigo InvestorRoom http://perrigo.investorroom.com/ Perrigo Announces FDA Final Approval For Hydrocodone Bitartrate And Homatropine Methylbromide Oral Solution http://perrigo.investorroom.com/2017-02-17-Perrigo-Announces-FDA-Final-Approval-For-Hydrocodone-Bitartrate-And-Homatropine-Methylbromide-Oral-Solution Fri, 17 Feb 2017 08:42:00 -0500 http://perrigo.investorroom.com/2017-02-17-Perrigo-Announces-FDA-Final-Approval-For-Hydrocodone-Bitartrate-And-Homatropine-Methylbromide-Oral-Solution Perrigo To Release Fourth Quarter And Calendar Year 2016 Results On February 27, 2017 http://perrigo.investorroom.com/2017-02-14-Perrigo-To-Release-Fourth-Quarter-And-Calendar-Year-2016-Results-On-February-27-2017 Tue, 14 Feb 2017 08:01:00 -0500 http://perrigo.investorroom.com/2017-02-14-Perrigo-To-Release-Fourth-Quarter-And-Calendar-Year-2016-Results-On-February-27-2017 Perrigo Confirms Patent Challenge For Generic Version Of Onexton® Gel http://perrigo.investorroom.com/2017-02-07-Perrigo-Confirms-Patent-Challenge-For-Generic-Version-Of-Onexton-R-Gel Tue, 07 Feb 2017 08:09:00 -0500 http://perrigo.investorroom.com/2017-02-07-Perrigo-Confirms-Patent-Challenge-For-Generic-Version-Of-Onexton-R-Gel Perrigo Announces Agreement With Starboard http://perrigo.investorroom.com/2017-02-07-Perrigo-Announces-Agreement-With-Starboard Company to Reconstitute Board with Five New Independent Directors Tue, 07 Feb 2017 08:02:00 -0500 http://perrigo.investorroom.com/2017-02-07-Perrigo-Announces-Agreement-With-Starboard Perrigo Announces FDA Approval Of Its First-To-File AB Rated Generic Version Of Topicort® Spray, 0.25% http://perrigo.investorroom.com/2017-01-24-Perrigo-Announces-FDA-Approval-Of-Its-First-To-File-AB-Rated-Generic-Version-Of-Topicort-R-Spray-0-25 Tue, 24 Jan 2017 08:40:00 -0500 http://perrigo.investorroom.com/2017-01-24-Perrigo-Announces-FDA-Approval-Of-Its-First-To-File-AB-Rated-Generic-Version-Of-Topicort-R-Spray-0-25